Podcast
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Top 12 Attributes of a Great MSL with Vanessa Jacobsen
Summary
In this episode, my guest is Vanessa Jacobsen. Vanessa is the Strategic External Engagement Director - Janssen Oncology, US Medical Affairs. We are going to talk about the top 12 attributes of a great MSL.
Key Points
- How to break into the industry
- The top 12 attributes that make a great MSL
- Specific scientific expertise
- Communication skills - purposeful and persuasive communication
- Ability to collaborate and partner
- Credibility
- Know your territory better than anyone
- Art of asking questions (knowing what to ask and how to ask)
- Excellent time management skills
- The environment of change and ambiguity
- Preparation
- Follow-up
- High Emotional Intelligence
- Enthusiasm
This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery.com.
The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.
MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.
MSL attributes, Medical Science Liaison, MSL career tips, Janssen Oncology, MSL podcast
Related Topics
You May Also Like
MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson
Podcast
MSL Talk: Tom Caravela
Over-Negotiation-How to Botch a Job Offer
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois
Sponsorship of oncology clinical trials in the United States according to age of eligibility
Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
Article
Karen Geary